Deceased-Donor Kidney Biopsy Scoring Systems for Predicting Future Graft Function: A Comparative Study

Transplant Proc. 2021 Apr;53(3):906-912. doi: 10.1016/j.transproceed.2020.09.002. Epub 2020 Dec 24.

Abstract

Background: Deceased-donor kidney quality pretransplantation is considered critical for future graft function. Assessment of donor kidney quality considers clinical and histologic variables. Several models that incorporate a variety of these factors have been proposed to predict long-term graft survival.

Methods: We compared the performance metrics of 4 scoring systems models---the Maryland Aggregate Pathology Index, Banff, Remuzzi, and Leuven---for predicting renal allograft survival. In this retrospective cohort study, we analyzed 173 renal allografts that underwent preoperative baseline biopsy. Donor demographics and donor baseline histopathology data were collected and correlated with graft survival posttransplant.

Results: Among the 4 scoring systems, none were significantly associated with posttransplant graft survival or early graft function. The Maryland Aggregate Pathology Index scoring system had better predictive capacity in receiver operating characteristic curve analysis; however, the utility as a predictor of graft survival was only slightly better than chance. Baseline histologic features were individually analyzed, and it was found that none were associated with graft survival in this cohort. Among donor demographics, none were significantly associated with graft survival.

Conclusions: In our study none of the 4 previously proposed predictive models were associated with graft survival after transplantation. Further studies are needed to define new models with stronger predictive value for graft outcome that could help minimize organ discards.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Female
  • Graft Survival*
  • Humans
  • Kidney / pathology*
  • Kidney Transplantation*
  • Male
  • Middle Aged
  • Research Design*
  • Retrospective Studies
  • Tissue Donors / supply & distribution*
  • Transplantation, Homologous